Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

2024.10.07

Sai Life Sciences' eco-friendly campus with green landscaping and modern architecture at sunset, featured in a blog post about the company's 2024 Sustainability Report

Sai Life Sciences releases Sustainability Report 2024

Sai Life Sciences, the fastest-growing Indian Contract Research, Development and Manufacturing Organization (CRDMO)[1], published its Sustainability Report for 2023-2024. Aligned with the Global Reporting Initiative (GRI) Universal Standards 2021 framework, this fifth edition of the Sustainability Report is based on the theme, ‘Synergising Sustainability, Performance and Growth.’ The full report can be read here.

Making the announcement, Krishna Kanumuri, CEO & Managing Director of Sai Life Sciences, said, “Overall, it has been a year of climate action for Sai Life Sciences. Today, renewable energy constitutes over 50% of our energy consumption at an organisational level. During the year, we also added newer decarbonisation levers to our programme, which have made significant contributions to reducing GHG emissions. This has been possible through sustained efforts, year on year, to strengthen our sustainability ecosystem and continually raise the bar.”


Last year, Sai Life Sciences renewed its Sustainable Development Goals (SDGs), outlining a clear roadmap to meet environmental, social, and governance (ESG) targets by March 31, 2027. The company has made notable progress in key areas, including reducing greenhouse gas emissions, sourcing energy from renewable sources and lowering specific water consumption. It has also exceeded its goal of providing education and livelihoods to 8,000 individuals from underprivileged communities through corporate social responsibility (CSR) programs. Women employees constitute 14.3% of the workforce, with numbers increasing year-on-year.

In recent years, Sai Life Sciences has made significant investments and progress in advancing its Sustainability agenda. Some of the notable highlights:

  1. Joined the Science Based Targets initiative (SBTi), committing to fight climate change with Science.
  2. Became the first India-headquartered company to join the Pharmaceutical Supply Chain Initiative (PSCI) membership.
  3. Strengthened culture of Health & Safety, along with making significant investments in upgrading infrastructure and systems.
  4. Won several prestigious awards for excellence in Environment, Health and Safety (EHS) practices and energy management.

[1] Among listed Indian peers in terms of revenue CAGR as well as EBITDA CAGR over FY22-24.

Share article

More News

2026.02.20

Sai Life Sciences to recruit 700+ professionals in FY27

Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), one of India’s leading integrated contract research, development and manufacturing organizations (CRDMOs), today announced plans to hire 700+ scientific, technical, and management professionals during 2026–27 as it scales capabilities to meet growing global demand for end-to-end drug discovery, development and manufacturing services.The recruitment will span roles […]
Read more

2026.02.06

Sai Life Sciences Limited delivers robust performance in 9MFY26

Revenue up by 43%; EBITDA up by 79%; Net Profit up by 199% Hyderabad, February 05, 2026: Sai Life Sciences Limited (BSE: 544306 I NSE: SAILIFE), one of India’s fastest growing Contract Research, Development and Manufacturing Organizations (CRDMO) announced its financial results for the third quarter and nine months ended December 2025. Financial Performance: Particulars […]
Read more

2026.01.28

Mabtech and Sai Life Sciences Announce Strategic Collaboration to Advance Immunology Research with EYRA Platform at Sai Boston Site

Mabtech, a global life science tools company specializing in advanced immunoassays, and Sai Life Sciences, a leading integrated Contract Research, Development, and Manufacturing Organization (CRDMO), today announced a strategic collaboration that establishes Sai’s Boston laboratory as a co-marketed US execution and demonstration hub for the Mabtech EYRA™ platform. Under this collaboration, Mabtech and Sai will […]
Read more

2026.01.12

Sai Life Sciences laboratories achieve Green Lab Certification

Sai Life Sciences has achieved Green Lab Certification for two PR&D laboratories and two Medicinal Chemistry laboratories under the My Green Lab (MGL) framework, with a compliance score of over 98%.The certification reflects the company’s systematic efforts to integrate sustainability into daily laboratory operations, with measurable reductions in energy consumption, water usage, waste generation, and […]
Read more

2025.12.19

Sai Life Sciences Releases Sustainability Report 2025

Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), one of India’s fastest-growing Contract Research, Development, and Manufacturing Organizations (CRDMO), today announced the release of its Sustainability Report for 2024–25. Aligned with the Global Reporting Initiative (GRI) Universal Standards 2021 and the Sustainability Accounting Standards Board (SASB) standards, this sixth edition is presented under the […]
Read more